Compare Davita Inc (DVA) vs HP Inc (HPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs HP Inc — how do they compare? Davita Inc trades at $179.02 (market cap $11.72B), while HP Inc trades at $29.11 (market cap $27.25B). The key difference: HP Inc is far larger — about 2.3× Davita Inc's market cap, and HP Inc pays a 4.03% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | HPQ | |
|---|---|---|
Market Cap | $11.72B | $27.25B |
Sector | Health | Technology |
52-Week High | $240.96 | $30.05 |
52-Week Low | $103.87 | $18.20 |
Enterprise Value | $24.44B | $34.41B |
Dividend Yield | — | 4.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
HPQ stock trades at $30.05, up 6.64% in the past 24 hours, with a bullish technical signal from moving averages and oscillators. The company reported Q2 FY2026 revenue of $14.4B, up 9% year-over-year, and non-GAAP EPS of $0.86, beating expectations by 21%. HPQ maintains a dividend yield near 4% with consistent payouts, while valuation metrics like P/E of 11.13 and P/S of 0.49 suggest potential undervaluation relative to peers. Recent news highlights AI-driven cost savings and a premium product mix fueling growth.
Outlook: HPQ benefits from AI PC upgrade cycle optimism and margin expansion, but faces risks from PC shipment declines and competitive pressures. Analyst consensus is mixed with 29% buy ratings, yet the stock trades above the $22.00 average price target, indicating limited near-term upside. Investors should weigh strong cash flow generation against industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
